Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
about
DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activationRapid cloning of high-affinity human monoclonal antibodies against influenza virusVaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanomaCo-administration of a DNA vaccine encoding the prostate specific membrane antigen and CpG oligodeoxynucleotides suppresses tumor growthInterferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006CpG Oligonucleotides as Cancer Vaccine AdjuvantsStructure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery systemBroad-Spectrum Drugs Against Viral AgentsRAGE is a nucleic acid receptor that promotes inflammatory responses to DNAAn in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapyPreexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge.Nasal vaccine innovation.Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.Activation of innate immunity in healthy Macaca mulatta macaques by a single subcutaneous dose of GMP CpG 7909: safety data and interferon-inducible protein-10 kinetics for humans and macaquesThe effect of TLR9 agonist CpG oligodeoxynucleotides on the intestinal immune response of cobia (Rachycentron canadum).Coccidioidomycosis: host response and vaccine developmentRapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.A hexanucleotide selected for increased cellular uptake in cis contains a highly active CpG-motif in human B cells and primary peripheral blood mononuclear cells.Immunostimulatory properties of phosphorothioate CpG DNA containing both 3'-5'- and 2'-5'-internucleotide linkages.Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategiesA dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motifFormulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccineDeoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoTreatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancerHuman TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs.Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology.Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.Do early childhood immunizations influence the development of atopy and do they cause allergic reactions?Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells.DNA from periodontopathogenic bacteria is immunostimulatory for mouse and human immune cellsBlood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantationEarly development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers.Role of NK cell subsets in organ-specific murine melanoma metastasis.CpG DNA as a vaccine adjuvant.Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9
P2860
Q24321675-98A36743-0CEB-4159-B34A-6C6769938432Q24644672-3988A7F4-D230-4653-8225-CFF451CF71E3Q24684238-D2487A9B-BFEF-4A6B-AEF3-62080DF0F1B7Q24794166-38E0904E-BF31-4E75-A60D-FACF3AE1BDD2Q24794822-20C89830-34D4-416A-AAE3-EC77E68A37FEQ26783826-2F4A0827-4080-40CB-B5C8-E81D8319C02FQ27004381-CDDFCB62-E6D7-4F31-A1ED-D005D55E6194Q27487859-CA25494B-561B-4984-80E7-BCAF592E5A6DQ27680115-123E7D03-4873-4369-A1F9-A1E4C0C54D72Q28729093-2BF4C3B1-10DF-4E85-A1BD-17189CBCC342Q30307037-24461C68-EDA7-44FB-8F38-017ED787659DQ30395810-C4B5B151-1773-488D-8A68-5F0B7401AF53Q31074458-F71F81AC-9963-4299-8C13-58C6A2C95F41Q31139969-B24B03F5-5EC1-4DB5-8999-3B21A009EB12Q31171481-1EA557C3-63C4-414B-B167-BABF50D2B40DQ33207983-558C9113-3612-40F2-848D-B4BBE43BEE87Q33211563-1E5103F4-3067-41BD-8858-27DA972B37BBQ33265100-79488B35-9F21-49D4-A977-7C4E0B414DD9Q33601167-DC78DD71-E8F2-4D4D-8EB1-042FD06C5F0FQ33613442-D450F908-FAD8-4849-82B5-A6664BE66612Q33716825-C2ED434C-377D-47CF-8293-4ABDCD49D1CAQ33781642-43142638-C735-428A-A7FF-FF23FBBADED4Q33788621-E125A954-3E13-44E6-ABD7-6734CBE88B74Q33792003-F616B51B-B83A-4BA3-8FBA-AD960E6AE300Q33930537-36E36D1F-5330-4560-BA42-436AA69BDBEFQ33946716-B87E6F56-09EB-45C6-9875-FF13289BF374Q34029664-3D615B45-AFA6-4CD2-A1E3-A04D6CAFD616Q34083770-2544D687-E1E5-412C-820A-EEE4F630DCDCQ34222728-AF827684-8A36-4BC4-84AB-6BF47F8781DFQ34340988-0F0F3084-03C6-4568-A31B-A554E1F586E1Q34355633-71269F31-B19F-4B70-8ED3-9D192EF8E9AEQ34368468-4E4A520A-B42A-4D87-9994-BEB318243F8AQ34532620-2E96E1C7-941B-400B-8720-9F712C4911D4Q34574238-87EBDE29-AB35-48B1-A8C5-E4D0461B4CC6Q34581285-43B1B8BA-9038-4ED9-8FE3-CC4335E1E4BFQ34618829-C732BD4B-D411-4664-9A43-E778CDC4C376Q34619324-155BE9B8-85E4-4937-9686-0AEEF51AB87AQ34775804-053E7F10-67E8-4B8B-99E2-9D25AE02416FQ35025722-C7B75B91-A0F0-4094-A424-BA9DF9300565Q35058952-05BE0D0F-1155-49F4-B071-BA129ED0CC39
P2860
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Delineation of a CpG phosphoro ...... esponses in vitro and in vivo.
@ast
Delineation of a CpG phosphoro ...... esponses in vitro and in vivo.
@en
type
label
Delineation of a CpG phosphoro ...... esponses in vitro and in vivo.
@ast
Delineation of a CpG phosphoro ...... esponses in vitro and in vivo.
@en
prefLabel
Delineation of a CpG phosphoro ...... esponses in vitro and in vivo.
@ast
Delineation of a CpG phosphoro ...... esponses in vitro and in vivo.
@en
P2093
P1476
Delineation of a CpG phosphoro ...... esponses in vitro and in vivo.
@en
P2093
Blackwell S
Hartmann G
Purcell RH
Rasmussen WL
P304
P356
10.4049/JIMMUNOL.164.3.1617
P407
P577
2000-02-01T00:00:00Z